| abstract |
The invention relates to a method for characterizing, in a biological sample, circulating tumor cells (CTCs) having at least one marker characteristic of the neoplastic nature of the cell, said marker being selected from the groups consisting of: the oncogenic proteins characteristic of the CTCs; and tumor markers. The invention also relates to the use of said method in the decision to use a treatment on a patient suffering from cancer. |